Crysalin was founded in June 2007 to research and develop crysalin lattice technology derived from patented work conducted since 2002 in the Oxford University Laboratory of Molecular Biophysics.
Crysalins are a protein-based nanotechnology with proven application in protein structure determination. Crysalins demonstrate significant advantages over other methodologies for protein structure determination since they are able to impose order on macromolecular targets to enable X-ray and EM instruments to resolve 3-D molecular structure where current technologies have failed (in particular: membrane proteins, soluble proteins with flexible regions). Crysalins also have the potential for use in biosensor development and optoelectronics.
Funding Rounds (1) - $2.4MUpdate
Current Team (4)Update
|Dec 20, 2010||OnBioVC - Crysalin raises 2400000 in venture round|
London, EC3V 3ND